Evidence map›Paper›PMID 24082101›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Discovery of novel chemoeffectors and rational design of Escherichia coli chemoreceptor specificity.

Shuangyu Bi, Daqi Yu, Guangwei Si, Chunxiong Luo, Tongqing Li, Qi Ouyang, Vladimir Jakovljevic, Victor Sourjik, Yuhai Tu, Luhua Lai

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Navigated range expansion promotes migratory culling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Identification of a dCache-type chemoreceptor inFrontiers in microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Real-time detection of response regulator phosphorylation dynamics in live bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Discovery of a New Chemoeffector forACS bio & med chem Au · 2022
    Article
  9. Article
  10. N-Formyl-L-aspartate mediates chemotaxis in spermFrontiers in cell and developmental biology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Microbiology and molecular biology reviews : MMBR · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Shuangyu BiBeijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, College of Chemistry and Molecular Engineering, Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, College of Physics, and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
Daqi Yu
Guangwei Si
Chunxiong Luo
Tongqing Li
Qi Ouyang
Vladimir Jakovljevic
Victor Sourjik
Yuhai Tu
Luhua Lai
Center for Interdisciplinary Studies · INState Key Laboratory for Structural Chemistry of Unstable and Stable SpeciesBeijing National Laboratory for Molecular Sciences · CNCenter for Life Sciences · CNHeidelberg University · DEIBM (United States) · USMax Planck Institute for Terrestrial Microbiology · DE

Funding

Thermally robust chemotaxis and thermotaxis in Escherichia coliR01GM082938 · NIGMS · PRINCETON UNIVERSITY · PI WINGREEN, NED S · 2008 to 2025
$5.5M
Quantitative Modeling of Signal Transduction in Bacterial ChemotaxisR01GM081747 · NIGMS · IBM THOMAS J. WATSON RESEARCH CENTER · PI TU, YUHAI · 2007 to 2018
$2.6M
NIGMS NIH HHS GM081747NIGMS NIH HHS GM082938NIGMS NIH HHS R01 GM081747NIGMS NIH HHS R01 GM082938
6 · The paper itself

Abstract

Bacterial chemoreceptors mediate chemotactic responses to diverse stimuli. Here, by using an integrated in silico, in vitro, and in vivo approach, we screened a large compound library and found eight novel chemoeffectors for the Escherichia coli chemoreceptor Tar. Six of the eight new Tar binding compounds induce attractant responses, and two of them function as antagonists that can bind Tar without inducing downstream signaling. Comparison between the antagonist and attractant binding patterns suggests that the key interactions for chemotaxis signaling are mediated by the hydrogen bonds formed between a donor group in the attractant and the main-chain carbonyls (Y149 and/or Q152) on the α4 helix of Tar. This molecular insight for signaling is verified by converting an antagonist to an attractant when introducing an N-H group into the antagonist to restore the hydrogen bond. Similar signal triggering effect by an O-H group is also confirmed. Our study suggests that the Tar chemoeffector binding pocket may be separated into two functional regions: region I mainly contributes to binding and region II contributes to both binding and signaling. This scenario of binding and signaling suggests that Tar may be rationally designed to respond to a nonnative ligand by altering key residues in region I to strengthen binding with the novel ligand while maintaining the key interactions in region II for signaling. Following this strategy, we have successfully redesigned Tar to respond to l-arginine, a basic amino acid that does not have chemotactic effect for WT Tar, by two site-specific mutations (R69'E and R73'E).

Indexed as

Amino Acid SubstitutionArginineBinding SitesEscherichia coliEscherichia coli ProteinsProtein Structure, SecondaryReceptors, Cell SurfaceSignal TransductionArginineEscherichia coli ProteinsReceptors, Cell SurfaceTar protein, E coli

Identifiers

PMID24082101
PMCPMC3801017
OpenAlexW2096824766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.